Clinical Trial Update: Use of Autologous Plasma Rich in Platelets and Extracellular Vesicles in the Surgical Treatment of Chronic Middle Ear Infections [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update on autologous platelet-rich plasma and extracellular vesicles for surgical treatment of chronic middle ear infections (Phase 2/Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Otitis Media Chronic
• Tympanic Membrane Perforation

Drugs mentioned

• Autologous Platelet-Rich Plasma (platelet-rich plasma)
• Extracellular vesicles

Snippet

Sponsor: University Medical Centre Ljubljana | Conditions: Otitis Media Chronic, Tympanic Membrane Perforation | Phase 2, Phase 3 | Status: UNKNOWN